Loading...
The effect of necitumumab in combination with gemcitabine-cisplatin on health-related quality of life (HRQOL) and tolerability: squire trial patients with epidermal growth factor receptor (EGFR)-expressing squamous NSCLC tumours.
Reck, M Socinski, M Szczesna, A Dediu, M Ramlau, R Losonczy, G Molinier, O Schumann, C Brown, J Soldatenkova, V
Reck, M
Socinski, M
Szczesna, A
Dediu, M
Ramlau, R
Losonczy, G
Molinier, O
Schumann, C
Brown, J
Soldatenkova, V
Citations
Altmetric:
Abstract
Description
Date
2016-11
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
The effect of necitumumab in combination with gemcitabine-cisplatin on health-related quality of life (HRQOL) and tolerability: squire trial patients with epidermal growth factor receptor (EGFR)-expressing squamous NSCLC tumours. 2016, 19(7):A748-A749 Value in Health